AzTrials
AzTrials

Proximal Interphalangeal Joint FractureNCT07714356

Evaluation of Suzuki Frame Fixation in Comminuted Fractures of the Proximal Interphalangeal Joint.

A study testing Suzuki Frame and Standard Conventional Treatment. in people with Proximal Interphalangeal Joint Fracture, run by Yehia Mohamed at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective randomized controlled trial aims to evaluate the functional and radiological outcomes of using the Suzuki frame for treating comminuted intra-articular fractures of the proximal interphalangeal (PIP) joint. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Proximal Interphalangeal Joint Fracture
What is being tested?
Suzuki Frame and Standard Conventional Treatment.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2 participants
Where
1 siteEgypt
Study dates
1 Jul 2026to 1 Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥18 years.
  • Either sex.
  • Simple or compound (open) fractures.
  • Isolated fracture involving a single finger.
  • Comminuted intra-articular proximal interphalangeal (PIP) joint fractures.

Who cannot join

  • Age <18 years.
  • Fractures involving the thumb.
  • Fractures involving the toes.
  • Near-total finger amputations.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site
  • Sohag University Hospitals

    Sohag

    Yahia Mohamed Esmail, +20 12 20709009, yehia_mohamed_post@med.sohag.edu.eg

Other trials in Egypt

About this study

This prospective randomized controlled trial aims to evaluate the functional and radiological outcomes of using the Suzuki frame for treating comminuted intra-articular fractures of the proximal interphalangeal (PIP) joint. The study involves adult patients with PIP joint fractures who will be treated using dynamic joint distraction (ligamentotaxis) via the Suzuki frame. The primary goal is to assess whether this technique facilitates early active finger motion, reduces joint stiffness, and improves long-term functional recovery compared to other methods.

Read the detailed description

Fractures involving the proximal interphalangeal (PIP) joint are challenging to manage, often leading to pain, stiffness, and functional impairment. Dynamic joint distraction using ligamentotaxis has emerged as an alternative to open surgery to facilitate early mobilization while avoiding the risks of soft-tissue dissection.

In this study, we are investigating the short-term functional and radiological outcomes of the Suzuki frame, which utilizes a 1.2-mm Kirschner wire axial traction pin and a hook pin connected by rubber bands to maintain joint congruency. Participants will include adults with isolated, comminuted intra-articular PIP joint fractures. Patients will be monitored over a 6-month follow-up period.

Clinical evaluation will include the Visual Analogue Scale (VAS) for pain and the QuickDASH score for functional disability. Radiological assessment will focus on joint alignment and reduction. The study will be conducted at Sohag University Hospital, following an intention-to-treat analysis principle.

Being tested
Suzuki Frame, Standard Conventional Treatment.
Keywords
Suzuki Frame, Comminuted Fracture, Ligamentotaxis, Dynamic Joint Distraction, Finger Fracture
Medical subject headings
Fractures, Comminuted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Suzuki FrameDevice

    Dynamic joint distraction using a 1.2-mm axial traction K-wire in the proximal phalanx, a 1.2-mm hook K-wire in the middle phalanx, and rubber bands to maintain joint congruency and facilitate early motion.

  • Standard Conventional Treatment.Procedure or surgery

    "tandard conventional management of comminuted intra-articular proximal interphalangeal joint fractures according to institutional protocols, including closed reduction and splinting or open reduction internal fixation as indicated.

Study groups in NCT07714356
Study groupRoleWhat they receive
Suzuki Frame Fixation GroupExperimentalPatients with comminuted intra-articular proximal interphalangeal (PIP) joint fractures treated with dynamic joint distraction using the Suzuki frame (1.2-mm Kirschner wires and rubber bands).
Receives: Device: Suzuki Frame
Standard Conventional Treatment GroupActive comparatorPatients with comminuted intra-articular proximal interphalangeal (PIP) joint fractures treated using standard conventional management as per hospital protocol (e.g., closed reduction and splinting or internal fixation).
Receives: Procedure: Standard Conventional Treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Outcome using the QuickDASH score.

    The QuickDASH score is a standardized tool used to measure upper limb functional ability. Higher scores indicate greater disability (range 0-100).

    Measured: 6 months post-operatively

Secondary outcomes (2)
  1. Pain assessment using the Visual Analogue Scale (VAS)

    Pain level assessed on a scale from 0 (no pain) to 10 (worst possible pain).

    Measured: 6 months post-operatively

  2. Range of Motion (ROM) of the PIP joint.

    Range of motion (ROM) expressed as the flexion-extension arc in degrees.

    Measured: 6 months post-operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2026
  2. Study start1 Jul 2026 (estimated)
  3. Primary completion1 Oct 2026 (estimated)
  4. Study completion1 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07714356
Sponsor's protocol ID
Soh-Med-26-3-15MS
Status last verified
Jul 2026
First submitted
15 Jul 2026
Last updated
20 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Suzuki Frame and Standard Conventional Treatment. in people with Proximal Interphalangeal Joint Fracture, run by Yehia Mohamed at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yahia Mohamed Esmail, MSc (+20 12 20709009, yehia_mohamed_post@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Outcome using the QuickDASH score. (time frame: 6 months post-operatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in